meRfi®-GM
Sporadic colorectal cancer (CRC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Sporadic colorectal cancer has traditionally been viewed in older individuals. However, as the global prevalence of the disease diagnosed in younger individuals (<50 years) is expected to increase within the next decade, greater recognition is now being given to early-onset colorectal cancer
Mutations that develop during an individual's lifetime can lead to a form of colorectal cancer (CRC) known as sporadic CRC. These mutations impact specific cells and their descendants. Notably, sporadic CRC represents about 95% of all CRC cases. CRC derived from mutations (caused by a mutation in the adenomatous polyposis coli gene (APC)) (Gao et al. …
References (Sources)
- A comprehensive framework for early-onset colorectal cancer research
- Colorectal carcinoma: a general overview and future perspectives in colorectal cancer
- Factors determining colorectal cancer: the role of the intestinal microbiota
- Familial Colorectal Cancer: Understanding the Alphabet Soup
- Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer
- Gut microbiota and colorectal cancer
- Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesisReview